| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |